Correlation Between Mangalam Drugs and Clean Science
Specify exactly 2 symbols:
By analyzing existing cross correlation between Mangalam Drugs And and Clean Science and, you can compare the effects of market volatilities on Mangalam Drugs and Clean Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangalam Drugs with a short position of Clean Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangalam Drugs and Clean Science.
Diversification Opportunities for Mangalam Drugs and Clean Science
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mangalam and Clean is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Mangalam Drugs And and Clean Science and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clean Science and Mangalam Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangalam Drugs And are associated (or correlated) with Clean Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clean Science has no effect on the direction of Mangalam Drugs i.e., Mangalam Drugs and Clean Science go up and down completely randomly.
Pair Corralation between Mangalam Drugs and Clean Science
Assuming the 90 days trading horizon Mangalam Drugs is expected to generate 1.16 times less return on investment than Clean Science. In addition to that, Mangalam Drugs is 1.52 times more volatile than Clean Science and. It trades about 0.14 of its total potential returns per unit of risk. Clean Science and is currently generating about 0.24 per unit of volatility. If you would invest 129,930 in Clean Science and on September 23, 2024 and sell it today you would earn a total of 15,175 from holding Clean Science and or generate 11.68% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Mangalam Drugs And vs. Clean Science and
Performance |
Timeline |
Mangalam Drugs And |
Clean Science |
Mangalam Drugs and Clean Science Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mangalam Drugs and Clean Science
The main advantage of trading using opposite Mangalam Drugs and Clean Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangalam Drugs position performs unexpectedly, Clean Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clean Science will offset losses from the drop in Clean Science's long position.Mangalam Drugs vs. Reliance Industries Limited | Mangalam Drugs vs. Tata Consultancy Services | Mangalam Drugs vs. HDFC Bank Limited | Mangalam Drugs vs. Bharti Airtel Limited |
Clean Science vs. Mangalam Drugs And | Clean Science vs. Kalyani Steels Limited | Clean Science vs. Zenith Steel Pipes | Clean Science vs. Kewal Kiran Clothing |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stocks Directory Find actively traded stocks across global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |